Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $1.19 billion. The enterprise value is $1.57 billion.
| Market Cap | 1.19B |
| Enterprise Value | 1.57B |
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPH has 45.95 million shares outstanding. The number of shares has decreased by -6.16% in one year.
| Current Share Class | 45.95M |
| Shares Outstanding | 45.95M |
| Shares Change (YoY) | -6.16% |
| Shares Change (QoQ) | -0.94% |
| Owned by Insiders (%) | 9.38% |
| Owned by Institutions (%) | 71.95% |
| Float | 34.80M |
Valuation Ratios
The trailing PE ratio is 11.41 and the forward PE ratio is 7.60. AMPH's PEG ratio is 6.85.
| PE Ratio | 11.41 |
| Forward PE | 7.60 |
| PS Ratio | 1.69 |
| Forward PS | 1.62 |
| PB Ratio | 1.55 |
| P/TBV Ratio | 5.82 |
| P/FCF Ratio | 10.51 |
| P/OCF Ratio | 7.82 |
| PEG Ratio | 6.85 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.63, with an EV/FCF ratio of 13.87.
| EV / Earnings | 14.07 |
| EV / Sales | 2.17 |
| EV / EBITDA | 7.63 |
| EV / EBIT | 10.48 |
| EV / FCF | 13.87 |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.85.
| Current Ratio | 3.12 |
| Quick Ratio | 2.07 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 3.08 |
| Debt / FCF | 5.80 |
| Interest Coverage | 4.51 |
Financial Efficiency
Return on equity (ROE) is 14.84% and return on invested capital (ROIC) is 6.72%.
| Return on Equity (ROE) | 14.84% |
| Return on Assets (ROA) | 5.84% |
| Return on Invested Capital (ROIC) | 6.72% |
| Return on Capital Employed (ROCE) | 10.26% |
| Revenue Per Employee | $356,659 |
| Profits Per Employee | $55,044 |
| Employee Count | 2,028 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.32 |
Taxes
In the past 12 months, AMPH has paid $24.04 million in taxes.
| Income Tax | 24.04M |
| Effective Tax Rate | 17.72% |
Stock Price Statistics
The stock price has decreased by -41.94% in the last 52 weeks. The beta is 0.92, so AMPH's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -41.94% |
| 50-Day Moving Average | 25.78 |
| 200-Day Moving Average | 26.13 |
| Relative Strength Index (RSI) | 52.38 |
| Average Volume (20 Days) | 471,589 |
Short Selling Information
The latest short interest is 4.19 million, so 9.13% of the outstanding shares have been sold short.
| Short Interest | 4.19M |
| Short Previous Month | 4.29M |
| Short % of Shares Out | 9.13% |
| Short % of Float | 12.05% |
| Short Ratio (days to cover) | 11.50 |
Income Statement
In the last 12 months, AMPH had revenue of $723.31 million and earned $111.63 million in profits. Earnings per share was $2.27.
| Revenue | 723.31M |
| Gross Profit | 357.04M |
| Operating Income | 149.94M |
| Pretax Income | 135.67M |
| Net Income | 111.63M |
| EBITDA | 205.73M |
| EBIT | 149.94M |
| Earnings Per Share (EPS) | $2.27 |
Balance Sheet
The company has $276.21 million in cash and $656.77 million in debt, giving a net cash position of -$380.56 million or -$8.28 per share.
| Cash & Cash Equivalents | 276.21M |
| Total Debt | 656.77M |
| Net Cash | -380.56M |
| Net Cash Per Share | -$8.28 |
| Equity (Book Value) | 776.75M |
| Book Value Per Share | 16.76 |
| Working Capital | 434.24M |
Cash Flow
In the last 12 months, operating cash flow was $152.28 million and capital expenditures -$39.02 million, giving a free cash flow of $113.26 million.
| Operating Cash Flow | 152.28M |
| Capital Expenditures | -39.02M |
| Free Cash Flow | 113.26M |
| FCF Per Share | $2.46 |
Margins
Gross margin is 49.36%, with operating and profit margins of 20.73% and 15.43%.
| Gross Margin | 49.36% |
| Operating Margin | 20.73% |
| Pretax Margin | 18.76% |
| Profit Margin | 15.43% |
| EBITDA Margin | 28.44% |
| EBIT Margin | 20.73% |
| FCF Margin | 15.66% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.16% |
| Shareholder Yield | 6.16% |
| Earnings Yield | 9.38% |
| FCF Yield | 9.52% |
Analyst Forecast
The average price target for AMPH is $35.17, which is 35.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $35.17 |
| Price Target Difference | 35.79% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 4.68% |
| EPS Growth Forecast (5Y) | 5.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 2.62 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.62 |
| Piotroski F-Score | 4 |